AZD-1390 Impairs Cell Mobility and Induces ROS-triggered Apoptotic Cell Death in Ovarian Cancer Cell Lines
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The Ataxia Telangiectasia mutation (ATM) codes for a protein for serine/threonine kinase. Phosphorylation of ATM prevents tumor formation by preserving genomic integrity. Somatic mutations in the ATM gene have been identified in some types of ovarian cancer. Therefore, in this study, we tested the anticancer effects of ATM inhibition with AZD-1390 in ovarian cancer cells to eliminate these mutations. Our results showed that AZD-1390 exhibited an antiproliferative effect by decreasing cell viability in ovarian cancer cells in a dose- and time-dependent manner. Further analysis revealed that AZD-1390 significantly inhibited the migration potential and increased ROS activity and apoptotic cell death. Our findings together suggest that ATM inhibition with AZD-1390 is effective in treating ovarian cancer cells and further investigation will contribute to this study.
Fields of Study & Subjects
Ovarian cancer diagnosis and treatment
PARP inhibition in cancer therapy
BRCA gene mutations in cancer
Publication details
- Journal / source
- Türk doğa ve fen dergisi :/Türk doğa ve fen dergisi
- Volume
- 15
- Issue
- 1
- Pages
- 152–159
- Publication date
- 30 March 2026
- Language
- TR